Document Detail


Disruption of coronary vasomotor function: the coronary spasm syndrome.
MedLine Citation:
PMID:  20946324     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Abnormal coronary vasoconstriction, or coronary spasm, can be the result of several factors, including local and neuroendocrine aberrations. It can manifest clinically as a coronary syndrome and plays an important role in the genesis of myocardial ischemia. Over the past half century, coronary angiography allowed the in vivo demonstration of spasm in patients who fit the initial clinical description of the condition as reported by Prinzmetal et al. Several clinical, basic, and more recently, genetic studies have provided insight into the pathogenesis, manifestations, and therapy of this condition. It is not uncommonly encountered in patients with coronary syndromes and absence of clearly pathologic lesions on angiography. Provocation tests utilizing pharmacologic and nonpharmacologic stimuli combined with imaging (echocardiography or coronary angiography) can help make the correct diagnosis. The use of calcium channel blockers and long-acting nitrates is currently considered standard of care and the overall prognosis appears to be good. The recent discovery of genetic abnormalities predisposing to abnormal spasm of the coronaries has stimulated interest in the development of targeted therapies for the management of this condition.
Authors:
George V Moukarbel; Larry A Weinrauch
Related Documents :
10421154 - Supraarterial decompression myotomy for myocardial bridging in a child.
6407354 - Coronary artery spasm during non-cardiac surgical procedure.
20014204 - Two brothers with myocardial infarction in the absence of atherosclerotic coronary arte...
3677824 - Malignant course of a benign anomaly: myocardial bridging.
1498134 - Successful heart transplantation with cardiac allografts exposed to carbon monoxide poi...
2522954 - Implications for patient triage from survival and left ventricular functional recovery ...
Publication Detail:
Type:  Journal Article     Date:  2010-10-14
Journal Detail:
Title:  Cardiovascular therapeutics     Volume:  30     ISSN:  1755-5922     ISO Abbreviation:  Cardiovasc Ther     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101319630     Medline TA:  Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  e66-73     Citation Subset:  IM    
Copyright Information:
© 2010 Blackwell Publishing Ltd.
Affiliation:
Brigham and Women's Hospital, Boston, MA, USA Harvard Medical School, Boston, MA, USA Mount Auburn Hospital, Cambridge, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.
Next Document:  MicroRNA-Based Therapeutic Approaches in the Cardiovascular System.